单细胞RNA测序解析人脑胶质瘤
弥漫性胶质瘤是最常见且不可治愈的原发性脑肿瘤,其生物学和临床过程由复杂的遗传与非遗传效应决定。当前认识主要基于批量基因组和转录组分析,掩盖了肿瘤内细胞多样性。本文综述了在临床胶质瘤样本中应用单细胞分析(尤其是RNA表达谱)的初步研究,这些研究为胶质瘤生物学、肿瘤异质性、癌细胞谱系、癌症干细胞程序、肿瘤微环境和胶质瘤分类提供了新见解。
要点
- 单细胞RNA测序可在细胞分辨率下解析胶质瘤内细胞多样性。
- 初步研究揭示了胶质瘤异质性、癌细胞谱系和干细胞程序。
- 单细胞分析为胶质瘤分类和微环境理解提供新视角。
核心结论
- 单细胞RNA测序研究为胶质瘤生物学、异质性、细胞谱系、干细胞程序、微环境和分类提供了新见解。
研究设计与样本
- 综述了在临床胶质瘤样本中部署单细胞分析(聚焦RNA表达谱)的初步研究。
主要发现
- 单细胞DNA和RNA谱分析进展使得在细胞分辨率下研究肿瘤成为可能。
- 这些研究提供了对胶质瘤生物学、肿瘤异质性、癌细胞谱系、癌症干细胞程序、肿瘤微环境和胶质瘤分类的新见解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diffuse gliomas are the most common human primary brain tumors and remain incurable. They are complex entities in which diverse genetic and nongenetic effects determine tumor biology and clinical course. Our current understanding of gliomas in patients is primarily based on genomic and transcriptomic methods that have profiled them as bulk, providing critical information yet masking the diversity of cells within each tumor. Recent advances in single-cell DNA and RNA profiling have paved the way to studying tumors at cellular resolution. Here, we review initial studies deploying single-cell analysis in clinical glioma samples, with a focus on RNA expression profiling. We highlight how these studies provide new insights into glioma biology, tumor heterogeneity, cancer cell lineages, cancer stem cell programs, the tumor microenvironment, and glioma classification.
引用
- Tirosh I, Suvà ML. Dissecting human gliomas by single-cell RNA sequencing. Neuro Oncol. 2018. PMID: 29016805. doi:10.1093/neuonc/nox126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。